茵栀黄口服液联合思密达治疗新生儿母乳性黄疸的临床疗效分析[ 摘要] 目的探究茵栀黄口服液联合思密达在治疗新生儿母乳性黄疸中的临床效果。方法从 201 2年7月到 201 4年3 月我院接诊的母乳性黄疸新生儿中选取80例作为本研究的研究对象。将这些病例按照入院时间的先后顺序均分为治疗组和对照组两个实验组,每组各 40 例。治疗组采用茵栀黄口服液联合思密达对患儿进行治疗, 对照组则采用传统常规手段进行治疗, 对两组患儿黄疸消退时间、住院时间以及血清总胆红素水平变化进行分析比较, 并根据相应的疗效标准对两组患儿的治疗效果进行评定统计,观察两组患儿的临床治疗效果。结果治疗组总有效率为 %, 明显高于对照组( %) ,血清总胆红素日均下降值治疗组为 ± μ mol/L ,也远远高于对照组( 27. 65± μ mol/L ) 。治疗组黄疸消退时间和住院时间也短于对照组, 差异具有统计学意义( P< )。结论茵栀黄口服液联合思密达在治疗新生儿母乳性黄疸上具有良好安全的临床效果, 能够有效地降低患儿的血清胆红素水平,缩短黄疸消退时间, 同传统常规手段相比疗效显著, 可以在临床上大力推广应用。[ 关键字] 新生儿;母乳性黄疸; 茵栀黄口服液; 思密达; 疗效分析 The curative effect analysis of yinzhihuang oral bined with smecta in treatment of 40 cases of breast milk jaundice of newborn [Abstract]Objecti veTo research the curative effect analysis of yinzhihuang oral bined with smecta in treatment of 40 cases of breast milk jaundice of newborn . Methods From July 2012 to March 2014, 80 cases with breast milk jaundice were selected in our hospital as the resear ch object. According to the sequence of admission time ,t hese cases were divided into the treatment group and the control group , each group of each 40 cases. The treatment group used yinzhihuang oral bined with smecta in the treatment . The control group was treated by conventional means . Analyzed pared the two groups of children with the time of jaundice, the hospitalization time and serum total bilirubin level changes . Acc
